Cargando…

Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial

INTRODUCTION: Serotonin reuptake inhibitors (SRIs) are widely used for the treatment of psychiatric disorders, including obsessive-compulsive disorder (OCD). SRIs commonly cause delayed orgasm, the mechanism of which is poorly understood. Oxytocin is involved in sexual function and is interconnected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Humble, Mats B., Bejerot, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005298/ https://www.ncbi.nlm.nih.gov/pubmed/27320409 http://dx.doi.org/10.1016/j.esxm.2016.04.002

Ejemplares similares

Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study
por: Humble, Mats B, et al.
Publicado: (2013)

Evidence-Based Brief Obsessive-Compulsive Scale
por: Bejerot, Susanne, et al.
Publicado: (2017)

The Brief Obsessive–Compulsive Scale (BOCS): A self-report scale for OCD and obsessive–compulsive related disorders
por: Bejerot, Susanne, et al.
Publicado: (2014)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Shahini, Najmeh, et al.
Publicado: (2021)

Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder
por: Vakili, Yaghoob, et al.
Publicado: (2015)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

Lamotrigine Augmentation of Serotonin Reuptake Inhibitors in Severe and Long-Term Treatment-Resistant Obsessive-Compulsive Disorder
por: Arrojo-Romero, Manuel, et al.
Publicado: (2013)

Adjunct Triptorelin in the Treatment of Obsessive-Compulsive Disorder in Clients Receiving Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Nikzad, Faezeh, et al.
Publicado: (2021)

Adjunctive therapeutic strategies in Obsessive-Compulsive Disorder resistant to serotonin reuptake inhibitors: a literature review
por: Regueira, P., et al.
Publicado: (2022)

Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis
por: Sassano-Higgins, Sean A., et al.
Publicado: (2015)

Cognitive Function before and during Treatment with Selective Serotonin Reuptake Inhibitors in Patients with Depression or Obsessive-Compulsive Disorder
por: Sayyah, Mehdi, et al.
Publicado: (2016)

Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial
por: Khalkhali, Mohammadrasoul, et al.
Publicado: (2016)

Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study
por: Chu, Che-Sheng, et al.
Publicado: (2016)

The effects of selective serotonin reuptake inhibitors on brain functional networks during goal-directed planning in obsessive–compulsive disorder
por: Kim, Minah, et al.
Publicado: (2020)

Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder
por: Keating, Charlotte, et al.
Publicado: (2013)

Rituximab for treatment-resistant schizophrenia and/or obsessive-compulsive disorder (OCD): functional connectivity and cytokines associated with symptomatic improvements
por: Humble, M. B., et al.
Publicado: (2023)

The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis
por: Kotapati, Vijaya Padma, et al.
Publicado: (2019)

Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis
por: Xu, Jiao, et al.
Publicado: (2021)

Serotonin transporter gene polymorphisms & obsessive-compulsive disorder
por: Nicolini, Humberto
Publicado: (2010)

Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder
por: Fineberg, Naomi A., et al.
Publicado: (2018)

Cognitive-Behavioral Therapy Versus Transcranial Direct Current Stimulation for Augmenting Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder Patients
por: Dadashi, Mohsen, et al.
Publicado: (2020)

Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series
por: Fornaro, Michele
Publicado: (2011)

Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive–compulsive disorder
por: Cappi, Carolina, et al.
Publicado: (2016)

The orgasmic history of oxytocin: Love, lust, and labor
por: Magon, Navneet, et al.
Publicado: (2011)

Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder
por: Umehara, Hidehiro, et al.
Publicado: (2016)

Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials
por: Dold, Markus, et al.
Publicado: (2015)

Efficacy of inhibitory learning theory-based exposure and response prevention and selective serotonin reuptake inhibitor in obsessive-compulsive disorder management: A treatment comparison
por: Samantaray, Narendra Nath, et al.
Publicado: (2018)

Reduced DNA methylation of the oxytocin receptor gene is associated with obsessive-compulsive disorder
por: Park, Chun Il, et al.
Publicado: (2020)

Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder
por: Müller-Vahl, K. R., et al.
Publicado: (2019)

Prevalence of Obsessive-Compulsive Spectrum Disorders in Obsessive-Compulsive Disorder
por: Siddiqui, Mohammad Aleem, et al.
Publicado: (2018)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

SUCCESSFUL TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER WITH ZIMELIDINE, A SEROTONIN RE-UPTAKE INHIBITOR
por: Prasad, Ashoka
Publicado: (1983)

Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder
por: Zhang, Kai, et al.
Publicado: (2019)

Author Correction: Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder
por: Müller-Vahl, K. R., et al.
Publicado: (2020)

Perceived Stress in Obsessive–Compulsive Disorder is Related with Obsessive but Not Compulsive Symptoms
por: Morgado, P., et al.
Publicado: (2013)

A comparison of symptom dimensions for obsessive compulsive disorder and obsessive compulsive-related disorders
por: Say Öcal, Derya, et al.
Publicado: (2019)

An analysis of the prevalence and impact of obsessive-compulsive personality disorder on the course of obsessive-compulsive disorder
por: Żerdziński, M., et al.
Publicado: (2023)

Obsessive Compulsive Symptoms, Obsessive Compulsive Disorder and Related Disorders in Idiopathic Parkinson’s Disease
por: Çakıroğlu, E., et al.
Publicado: (2023)

Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder
por: Yamamoto, Haruka, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a5rebo781p9ui1al57g08ofid3